Analysis: Can States Fix The Disaster Of American Health Care?
The governor of California has proposed some big ideas. Who knows whether he can pull them off, but there鈥檚 reason for hope.
The independent source for health policy research, polling, and news.
421 - 440 of 698 Results
The governor of California has proposed some big ideas. Who knows whether he can pull them off, but there鈥檚 reason for hope.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
As drugmakers hike prices, interest to rein them in grows on Capitol Hill. Next week marks the anniversary of Roe v. Wade, the Supreme Court鈥檚 abortion decision, and both the House, whose leaders back abortion rights, and the Senate, controlled by abortion foes, are holding statement votes. And the government shutdown is still affecting health programs. Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Alice Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss these issues.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Loretta Boesing is on a mission to make sure prescription drugs delivered by mail are safe and effective. The life of her son 鈥 and others who order medicine by mail 鈥 could depend on it, she says.
Just hours into his tenure as California鈥檚 new governor, Democrat Gavin Newsom proposed major plans to insure more Californians, including state-funded financial aid for health insurance and a requirement for Californians to have coverage.
A reporter with a serious peanut allergy explains what it is like to process news reports that tout new pharmaceutical products that might minimize the danger of accidental exposure.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
The program that provides health care for about half of the U.S. territory鈥檚 population cannot afford to cover the drugs.
From Medicare dental coverage to drug prices to fetal tissue research, the panelists answer listeners鈥 questions. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Paige Winfield Cunningham of The Washington Post join KHN鈥檚 Julie Rovner.
Utah's Orrin Hatch is leaving the Senate, after 42 years. The Republican led bipartisan efforts to provide health care to more kids and AIDS patients. He also thrived on donations from the drug industry.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
The fallout continues from that Texas court decision that ruled Congress鈥 2017 elimination of the tax penalty for failing to have insurance rendered the entire Affordable Care Act unconstitutional. Meanwhile, enrollment for 2019 at healthcare.gov was down, but far less than many predicted. KHN鈥檚 Julie Rovner, along with panelists Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of the Washington Examiner, discuss this, plus the best, most overhyped and nerdiest stories of 2018. Also, Rovner interviews GOP strategist and pollster Frank Luntz.
There could be a long legal struggle ahead over the decision by a judge in Texas to invalidate the federal health law. But if his decision stands, it would have long-lasting effects on health care from insurance coverage to Medicare payments to privacy protections.
Biologic drugs, made from living organisms, are big moneymakers partly because they have little competition from 鈥渂iosimilars.鈥 It鈥檚 a very different story in Europe.
The leaders of California鈥檚 legislative health committees who wield power over state health policy have been showered with money from the health care sector, with drug companies, health plans, hospitals and doctors providing nearly 40 percent of their 2017-18 campaign funds.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
It鈥檚 a little-known secret that patients can get thousands of dollars directly from a drugmaker.
The case of a Michigan woman told to fundraise $10,000 for a heart transplant sparked viral outrage, but experts say 鈥渨allet biopsies鈥 are common.
漏 2026 KFF